HomeYATHARTH › Filing
🔔 Get instant alerts when YATHARTH files quarterly results on BSE Start free trial →

We hereby submit Earnings Call Transcript Q1FY27.

Filed: 18 Aug 2026, 17:13 IST Exchange: BSE Category: Financial Results — Earnings Call Transcript
AI summary - Q1FY27 revenue reached INR3,927 million, up 51% y-y; EBITDA INR917 million, PAT INR454 million - New hospitals contributed 27% of revenue; Faridabad Sector 20 hospital breakeven in 9 months - Group ARPOB rose 7% y-y to INR34,758; premium hospitals crossed INR50,000 ARPOB - EBITDA margin adjusted for new hospitals at 28.1%; group targets 24-25% EBITDA margin for FY27 - Capacity at 2,555 beds; target 5,000 beds within ~2.5 years, including Gurugram opening Q1FY28 - New hospitals expected to reach 15-20% EBITDA margin within 15 months post breakeven - Capex per bed rising to INR75-80 lakhs due to equipment and real estate costs - Payer mix: government ~40%, newer hospitals <10%; focus on cash/private insurance - ARPOB growth guidance 8-10% y-y; revenue growth and margins expected to surpass FY26 levels
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 YATHARTH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add YATHARTH to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Yatharth Hospital & Trauma Care Services Limited

Important. The summary above is generated automatically from Yatharth Hospital & Trauma Care Services Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.